PT  - JOURNAL ARTICLE
AU  - Olivier Poirion
AU  - Kumardeep Chaudhary
AU  - Sijia Huang
AU  - Lana X. Garmire
TI  - Multi-omics-based pan-cancer prognosis prediction using an ensemble of deep-learning and machine-learning models
AID  - 10.1101/19010082
DP  - 2019 Jan 01
TA  - medRxiv
PG  - 19010082
4099  - http://medrxiv.org/content/early/2019/10/25/19010082.short
4100  - http://medrxiv.org/content/early/2019/10/25/19010082.full
AB  - The prognosis prediction of cancer patients is important for disease management. We introduce DeepProg, a new computational framework that robustly predicts patient survival subtypes based on multiple types of omic data, using an ensemble of deep-learning and machine-learning models. We apply DeepProg on 32 cancer datasets from TCGA and identified multiple cancer survival subtypes. Patient survival risk-stratification based on DeepProg is significantly better (p-value=7.9e-7 rank sum test) than Similarity Network Fusion based multi-omics data integration in all cancer types. Further comprehensive pan-cancer comparative analysis unveils the genomic signatures common among all the poorest survival subtypes, with genes enriched in extracellular matrix modeling, immune deregulation, and mitosis processes. Furthermore, models built on closely related cancer types using DeepProg are predictive of the subtypes of some other cancers, demonstrating the utility of DeepProg for transfer learning.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by grants K01ES025434 awarded by NIEHS through funds provided by the trans-NIH Big Data to Knowledge (BD2K) initiative (www.bd2k.nih.gov), P20 COBRE GM103457 awarded by NIH/NIGMS, R01 LM012373 and R01 LM012907 awarded by NLM, and R01 HD084633 awarded by NICHD to L.X. Garmire.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableData are available upon request